Your browser doesn't support javascript.
loading
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup.
Bruno, W; Dalmasso, B; Barile, M; Andreotti, V; Elefanti, L; Colombino, M; Vanni, I; Allavena, E; Barbero, F; Passoni, E; Merelli, B; Pellegrini, S; Morgese, F; Danesi, R; Calò, V; Bazan, V; D'Elia, A V; Molica, C; Gensini, F; Sala, E; Uliana, V; Soma, P F; Genuardi, M; Ballestrero, A; Spagnolo, F; Tanda, E; Queirolo, P; Mandalà, M; Stanganelli, I; Palmieri, G; Menin, C; Pastorino, L; Ghiorzo, P.
Afiliação
  • Bruno W; IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy; University of Genoa, Department of Internal Medicine and Medical Specialties (DiMI), Genoa, Italy. Electronic address: william.bruno@unige.it.
  • Dalmasso B; IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy.
  • Barile M; IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy.
  • Andreotti V; IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy.
  • Elefanti L; Immunology and Diagnostic Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Colombino M; Unit of Cancer Genetics, Institute of Genetics and Biomedical Research of the National Research Council (IRGB-CNR), Sassari, Italy.
  • Vanni I; IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy; University of Genoa, Department of Internal Medicine and Medical Specialties (DiMI), Genoa, Italy.
  • Allavena E; University of Genoa, Department of Internal Medicine and Medical Specialties (DiMI), Genoa, Italy.
  • Barbero F; IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy.
  • Passoni E; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Merelli B; Oncology Unit, ASST Papa Giovanni XXIIII, Bergamo, Italy.
  • Pellegrini S; Immunology and Diagnostic Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy; Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, Padua, Italy.
  • Morgese F; Oncology Unit, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
  • Danesi R; Romagna Cancer Registry, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
  • Calò V; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
  • Bazan V; Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy.
  • D'Elia AV; Institute of Medical Genetics, ASUFC University Hospital of Udine, Udine, Italy.
  • Molica C; Medical Oncology Unit, S. Maria della Misericordia Hospital, Perugia, Italy.
  • Gensini F; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.
  • Sala E; Cytogenetics and Medical Genetics Unit, H San Gerardo ASST Monza, Monza, Italy.
  • Uliana V; Medical Genetics Unit, AOU di Parma, Parma, Italy.
  • Soma PF; Casa di Cura Gibiino, Catania, Italy.
  • Genuardi M; Fondazione Policlinico Universitario A. Gemelli IRCCS, Medical Genetics Unit, Rome, Italy; Università Cattolica del Sacro Cuore, Department of Life Sciences and Public Health, Rome, Italy.
  • Ballestrero A; IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy; University of Genoa, Department of Internal Medicine and Medical Specialties (DiMI), Genoa, Italy.
  • Spagnolo F; IRCCS Ospedale Policlinico San Martino, Medical Oncology 2, Genoa, Italy.
  • Tanda E; IRCCS Ospedale Policlinico San Martino, Medical Oncology 2, Genoa, Italy.
  • Queirolo P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Mandalà M; Medical Oncology Unit, S. Maria della Misericordia Hospital, Perugia, Italy; Department of Surgery and Medicine, University of Perugia, Perugia, Italy.
  • Stanganelli I; Skin Cancer Unit, IRCCS IRST Istituto Scientifico Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST) IRCCS, Meldola, Italy; Dermatologic Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Palmieri G; Unit of Cancer Genetics, Institute of Genetics and Biomedical Research of the National Research Council (IRGB-CNR), Sassari, Italy.
  • Menin C; Immunology and Diagnostic Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Pastorino L; IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy; University of Genoa, Department of Internal Medicine and Medical Specialties (DiMI), Genoa, Italy.
  • Ghiorzo P; IRCCS Ospedale Policlinico San Martino, Genetics of Rare Cancers, Genoa, Italy; University of Genoa, Department of Internal Medicine and Medical Specialties (DiMI), Genoa, Italy.
ESMO Open ; 7(4): 100525, 2022 08.
Article em En | MEDLINE | ID: mdl-35777164
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Cutâneas / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Cutâneas / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: ESMO Open Ano de publicação: 2022 Tipo de documento: Article